Mon. 4 Mar 2024, 4:15pm ET
Benzinga
Earnings, Earnings Beats, News
Akoya Biosciences (NASDAQ:AKYA) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.28) by 21.43 percent. The company reported quarterly sales of $26.49 million which beat the analyst consensus estimate of $25.89 million by 2.31 percent. This is a 24.83 percent increase over sales of $21.22 million the same period last year.